Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Signals from the Adipose Microenvironment and the Obesity-Cancer Link-A Systematic Review.

Himbert C, Delphan M, Scherer D, Bowers LW, Hursting S, Ulrich CM.

Cancer Prev Res (Phila). 2017 Sep;10(9):494-506. doi: 10.1158/1940-6207.CAPR-16-0322. Review.

PMID:
28864539
2.

SGBS cells as a model of human adipocyte browning: A comprehensive comparative study with primary human white subcutaneous adipocytes.

Yeo CR, Agrawal M, Hoon S, Shabbir A, Shrivastava MK, Huang S, Khoo CM, Chhay V, Yassin MS, Tai ES, Vidal-Puig A, Toh SA.

Sci Rep. 2017 Jun 22;7(1):4031. doi: 10.1038/s41598-017-04369-2.

3.

Steroidogenic enzyme expression in estrogen production in the goat gastrointestinal (GI) tract and the effect of castration.

Mohibbi H, Qasimi MI, Nagaoka K, Watanabe G.

J Vet Med Sci. 2017 Jul 19;79(7):1253-1260. doi: 10.1292/jvms.17-0093. Epub 2017 Jun 2.

4.

Ghrelin and Breast Cancer: Emerging Roles in Obesity, Estrogen Regulation, and Cancer.

Au CC, Furness JB, Brown KA.

Front Oncol. 2017 Jan 9;6:265. doi: 10.3389/fonc.2016.00265. eCollection 2016. Review.

5.

Aromatase expression and regulation in breast and endometrial cancer.

Zhao H, Zhou L, Shangguan AJ, Bulun SE.

J Mol Endocrinol. 2016 Jul;57(1):R19-33. doi: 10.1530/JME-15-0310. Epub 2016 Apr 11. Review.

6.

Structural and functional characterization of aromatase, estrogen receptor, and their genes in endocrine-responsive and -resistant breast cancer cells.

Chan HJ, Petrossian K, Chen S.

J Steroid Biochem Mol Biol. 2016 Jul;161:73-83. doi: 10.1016/j.jsbmb.2015.07.018. Epub 2015 Aug 13. Review.

7.

Impact of exogenous gonadotropin stimulation on circulatory and follicular fluid cytokine profiles.

Baskind NE, Orsi NM, Sharma V.

Int J Reprod Med. 2014;2014:218769. doi: 10.1155/2014/218769. Epub 2014 Nov 30.

8.

Interaction of JAK with steroid receptor function.

Gupta N, Mayer D.

JAKSTAT. 2013 Oct 1;2(4):e24911. doi: 10.4161/jkst.24911. Epub 2013 May 7. Review.

9.

Glucocorticoid-induction of hypothalamic aromatase via its brain-specific promoter.

Brooks DC, Zhao H, Yilmaz MB, Coon V JS, Bulun SE.

Mol Cell Endocrinol. 2012 Oct 15;362(1-2):85-90. doi: 10.1016/j.mce.2012.05.012. Epub 2012 Jun 13.

10.

Estrogen, male dominance and esophageal adenocarcinoma: is there a link?

Yang H, Sukocheva OA, Hussey DJ, Watson DI.

World J Gastroenterol. 2012 Feb 7;18(5):393-400. doi: 10.3748/wjg.v18.i5.393. Review.

11.

Obesity, inflammation, and postmenopausal breast cancer: therapeutic implications.

Macciò A, Madeddu C.

ScientificWorldJournal. 2011;11:2020-36. doi: 10.1100/2011/806787. Epub 2011 Oct 27. Review.

12.

Potential utility of natural products as regulators of breast cancer-associated aromatase promoters.

Khan SI, Zhao J, Khan IA, Walker LA, Dasmahapatra AK.

Reprod Biol Endocrinol. 2011 Jun 21;9:91. doi: 10.1186/1477-7827-9-91. Review.

13.

Obesity, inflammatory markers, and endometrial cancer risk: a prospective case-control study.

Dossus L, Rinaldi S, Becker S, Lukanova A, Tjonneland A, Olsen A, Stegger J, Overvad K, Chabbert-Buffet N, Jimenez-Corona A, Clavel-Chapelon F, Rohrmann S, Teucher B, Boeing H, Schütze M, Trichopoulou A, Benetou V, Lagiou P, Palli D, Berrino F, Panico S, Tumino R, Sacerdote C, Redondo ML, Travier N, Sanchez MJ, Altzibar JM, Chirlaque MD, Ardanaz E, Bueno-de-Mesquita HB, van Duijnhoven FJ, Onland-Moret NC, Peeters PH, Hallmans G, Lundin E, Khaw KT, Wareham N, Allen N, Key TJ, Slimani N, Hainaut P, Romaguera D, Norat T, Riboli E, Kaaks R.

Endocr Relat Cancer. 2010 Oct 29;17(4):1007-19. doi: 10.1677/ERC-10-0053. Print 2010 Dec.

14.

A novel promoter controls Cyp19a1 gene expression in mouse adipose tissue.

Zhao H, Innes J, Brooks DC, Reierstad S, Yilmaz MB, Lin Z, Bulun SE.

Reprod Biol Endocrinol. 2009 Apr 24;7:37. doi: 10.1186/1477-7827-7-37.

15.

Polymorphisms in CYP1B1, GSTM1, GSTT1 and GSTP1, and susceptibility to breast cancer.

Van Emburgh BO, Hu JJ, Levine EA, Mosley LJ, Perrier ND, Freimanis RI, Allen GO, Rubin P, Sherrill GB, Shaw CS, Carey LA, Sawyer LR, Miller MS.

Oncol Rep. 2008 May;19(5):1311-21.

16.

CCAAT/enhancer binding protein beta regulates aromatase expression via multiple and novel cis-regulatory sequences in uterine leiomyoma.

Ishikawa H, Fenkci V, Marsh EE, Yin P, Chen D, Cheng YH, Reisterd S, Lin Z, Bulun SE.

J Clin Endocrinol Metab. 2008 Mar;93(3):981-91. doi: 10.1210/jc.2007-2507. Epub 2008 Jan 8. Erratum in: J Clin Endocrinol Metab. 2009 Apr;94(4):1476. Fencki, Veysel [corrected to Fenkci, Veysel].

17.

Aromatase excess in cancers of breast, endometrium and ovary.

Bulun SE, Chen D, Lu M, Zhao H, Cheng Y, Demura M, Yilmaz B, Martin R, Utsunomiya H, Thung S, Su E, Marsh E, Hakim A, Yin P, Ishikawa H, Amin S, Imir G, Gurates B, Attar E, Reierstad S, Innes J, Lin Z.

J Steroid Biochem Mol Biol. 2007 Aug-Sep;106(1-5):81-96. Epub 2007 May 24.

18.

Functional characterization of W147A: a high-affinity interleukin-11 antagonist.

Underhill-Day N, McGovern LA, Karpovich N, Mardon HJ, Barton VA, Heath JK.

Endocrinology. 2003 Aug;144(8):3406-14.

19.

Inhibition of IL-6+IL-6 soluble receptor-stimulated aromatase activity by the IL-6 antagonist, Sant 7, in breast tissue-derived fibroblasts.

Purohit A, Singh A, Ghilchik MW, Serlupi-Crescenzi O, Reed MJ.

Br J Cancer. 2003 Feb 24;88(4):630-5.

20.

The role of cytokines in regulating estrogen synthesis: implications for the etiology of breast cancer.

Purohit A, Newman SP, Reed MJ.

Breast Cancer Res. 2002;4(2):65-9. Epub 2002 Jan 14. Review.

Supplemental Content

Support Center